Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
anticipates receiving results and announcing topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults (60 years of age and older). In addition, management will provide an update on its prior Phase 2 and Phase 3 clinical trials in older adults, as well as its RSV Phase 3 clinical trial for infants via maternal immunization, known as Prepareâ„¢, which continues to experience significant acceleration in enrollment and enhanced momentum heading into its third global season.
I really can't c why they would set up not only a conference call but a web cast, just to give us bad news.
Always. :)
The last study was skewed, they schedule call on Monday for updated, I'm thinking it will b good.
I believe so, they were authorized. But I have seen no news of it being closed
I know they did a securities registration back in January.
I agree, I loaded .90's, but still grabbing a few on the dips.
They are shaking the tree.
Coming soon
Shorties starting to get squeezed
YES SIR
YUP
Shorts covering @ will right now, need more valine, GLTA
Agreed
:)
??
New HOD
Or being raided by SEC. LOL
IBB is getting hit today, looks like most pharma is down.
They are waiting on approval, just standard procedure, then it will b final.
LOL
I'll wait
Same here, GLTA
50+ million shorts here, they are swamping the ask. We need more volume to push them out.
Exactly! GE doesn't give a damn about his shareholders! New R/S coming soon
Nobody knows the bottom except CROOKED GEORGE
I agree, it is only considered dead on opinion, no news.
You might as well get your news out of a comic book than WSJ
If results are good, back to $8 plus
Descent volume today, hopefully some good news soon
LMAO
The regulatory approval on liscence agreement, should b sooner and a catalyst
I'm loaded, and agree
:)
That must be a bugs bunny chart, lol
IMO, insider buying says it all,
Churn baby churn